Palonosetron for Prevention of Biochemotherapy Induced Nausea and Vomiting

Summary

Primary Objectives: * Safety of palonosetron administered for control of nausea and vomiting in patients with metastatic melanoma receiving biochemotherapy. * To determine the patterns and severity of nausea and vomiting in two groups of patients with metastatic melanoma receiving biochemotherapy with palonosetron premedication using two schedules of palonosetron administration.

Timeline

Start

2006-11

Primary completion

2009-05

Completion

2009-05

Drugs

Indications